Briggs Morrison Email

CEO, President . Crossbow Therapeutics

Current Roles

Employees:
38
Revenue:
$5.9M
About
Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt™ therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.
Crossbow Therapeutics Address

Cambridge, MA
United States
Crossbow Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.